Clinical Trial Update: Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing sildenafil for safety and efficacy in newborns with persistent pulmonary hypertension (PPHN) has been terminated with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic Respiratory Failure
• Persistent Pulmonary Hypertension of the Newborn

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: PPHN, Persistent Pulmonary Hypertension of the Newborn | Phase 2 | Status: TERMINATED | Results posted: 2012-12-03